A notable advancement in diabetes management is emerging with the introduction of tirzepatide in a 45mg form. This new version builds upon the existing success of tirzepatide, a dual GIP and GLP-1 target, and offers a https://tiffanyujiu545104.eqnextwiki.com/5725801/groundbreaking_development_tirzepatide_dose_for_glucose_control